Skip to main content
. 2020 May 11;21(9):3392. doi: 10.3390/ijms21093392
IR
MCL
PTL
DMAMCL
Irradiation
Micheliolide
Parthenolide
Dimethylamino Michael adduct of MCL
NSCLC Non-small-cell lung cancer
IC50
DSB
HIF-1α
Inhibitory concentration at 50% growth
DNA double-strand break
Hypoxia-inducible factor-1α
VEGF Vascular endothelial growth factor
CHX Cycloheximide
SF2 Survival fraction at 2 Gy
Dq Quasithreshould dose
SERDq
NF-κB
HDAC
Sensitizer enhancement ratio for Dq
Nuclear factor kappa B
Histone deacetylase